Point of care testing (POCT) enables rapid diagnostic tests to be performed while the patient is at the point of care facility where results can be obtained immediately, rather than waiting hours or even days for outside lab results to arrive. Point of care testing covers: blood glucose testing, blood gas and electrolytes analysis, rapid coagulation testing, rapid cardiac markers diagnostics, drugs of abuse screening, urine strips testing, pregnancy testing, fecal occult blood analysis, food pathogens screening, hemoglobin diagnostics, infectious disease testing and cholesterol screening.
This report describes latest developments in the point of care testing market segment. It examines clinical instruments, devices and reagents and supplies as utilized in near-patient environments like hospital emergency rooms, critical care units, clinics and doctor's offices. The study defines the dollar volume of point of care sales and makes five year projections - both in the U.S. and worldwide - including Europe, Asia and Latin America.
It also examines in detail the point of care sector for 25 individual country markets. A detailed summary of all important instruments in each clinical market is provided with emphasis on newly introduced products. Moreover, parallel areas where rapid detection is important using hand-held devices such as rapid detection of food pathogens and infectious diseases (MRSA, herpes simplex, avian flu, West Nile virus and typhoid) are discussed. Growth moderators and developing trends in point of care applications, as well as technology platform innovations and connectivity questions are examined in detail.
The report surveys almost all of the companies known to be marketing, manufacturing or developing instruments and reagents for the point of care market in the U.S. and worldwide. Each company is discussed in depth, with a section on its history, product lines, business and marketing analysis, and a subjective commentary of the company's market position. Detailed tables and charts with sales forecasts and market data are also included.
Key Topics Covered:
2. Overview of Diagnostic Testing Point of Care Markets
2.1 Key Issues in the POC Diagnostic Testing Sector
2.2 Global Point of Care Marketplace
2.3 Shifts from Central Lab Testing to POCT
2.4 Geographical Distribution
2.5 Challenges of POCT
2.6 Key Issues for POCT
2.7 The Future of POCT
3. Summary Analysis of the Global POCT Market: Value, Growth Rates and Market Share
3.1 Global POCT Market
3.2 Global Market Revenues Analysis by Market Segment
3.3 Global Market Share Analysis
3.4 Global Market Size by Geographic Location
3.5 Global Market Size by Analyte Market Segment
3.6 Global POCT Testing by Location
4. Analysis of the U.S. POCT Market: Value, Growth Rates and Market Share
4.1 U.S. Market Revenues Analysis by Market Segment
4.2 U.S. Market Share Analysis
4.3 U.S. Market Size by Analyte Market Segment
5. Analysis of the European POCT Market: Value, Growth Rates and Market Shares
5.1 European Market Revenues Analysis
5.2 European Market Revenues Analysis by Geographic Region
5.3 European Market Revenues Analysis by Market Segment
5.4 European Market Share Analysis
6. Analysis of the POCT Markets for Japan, China and India: Value, Growth Rates and Market Share
6.1 Summary Analysis of Japanese, Chinese and Indian POCT Market Revenues
6.2 Summary of Asian (Japanese, Chinese and Indian) Market Revenues by Market Segment
6.3 Asian (Japanese, Chinese and Indian) Market Share Analysis
6.4 Summary Analysis of the Japanese POCT Market
6.5 Summary Analysis of the Indian POCT Market
6.6 Summary Analysis of the Chinese POCT Market
7. Analysis of the Rest of World (ROW) POCT Market: Value, Growth Rates and Market Share
7.1 Summary Analysis of the ROW POCT Market Revenues
7.2 Summary of the ROW Market Revenues by Market Segment
7.3 ROW Market Share Analysis
7.4 Summary Analysis of the ROW POCT Market Revenues
8. Review of the Market Segments, Reagents and Equipment
8.1 Blood Glucose Monitoring
8.2 Blood Gas and Electrolytes
8.3 Rapid Coagulation Tests
8.4 POC Rapid Cardiac Markers
8.5 POCT Substance Abuse Testing
8.6 POC Pregnancy and Fertility Tests
8.7 Fecal Occult Blood
8.8 POC Infectious Disease Testing
8.9 POC Urine Strip Testing
8.10 POC Cholesterol Testing
8.11 Miscellaneous POC Tests
9. POCT: Growth Regulators
9.1 Moderators of Growth
9.2 Personnel Acceptance
9.3 Key People for POCT
9.4 Information Management Issues
9.5 Key Elements for POCT
9.6 POCT and Reimbursement
9.7 Effectiveness of Clinical Outcomes
9.8 Rapid Near-Patient Testing in Hospitals
9.9 Satellite Facilities
9.10 Regionalization of Laboratory Care
9.11 Requirements for POCT
9.12 Locations of POC for Patient Care
9.13 Benefits of POCT
9.14 Cost Elements of POCT
9.15 Necessary Functions in POCT
9.16 Turnaround Time (TAT) for POCT
9.17 Clinical Laboratory Improvement Amendments (CLIA)
9.18 Sexually-Transmitted Diseases in Underdeveloped Countries
9.19 Sources of Error in POC Testing
10. Business Trends in the POC Sector
10.1 Sector Consolidation
10.2 Diagnostic Testing Growth Trends
10.3 Acquisition, License Agreements, Internal Development and Partnerships
10.4 Product Testing Depth in POCT
10.5 Government Regulation
10.6 Post-Filing Regulations for POC Devices
10.7 Exporting Unapproved POCTs
10.8 Analyte-Specific Reagents (Home-Brew Tests)
10.9 Medical Device Registration
10.10 Product Labeling
10.11 Punitive FDA Actions
10.12 CLIA 88 and State Laboratory Laws
10.13 Impact of Regulations on the Industry
10.14 Minimizing Regulatory Barriers
10.15 Waived Testing
11. Technology Platform Innovations in POCT
11.1 Latest POCT Technological Platforms
11.2 Smart Phone Technology
11.3 QuantuMDx Handheld, Portable Low Cost Rapid Devices
12. Data Management and Connectivity
12.1 Wireless LANs
12.2 Connectivity Platforms
12.3 Advantages of POCT Connectivity
13. Corporate Profiles
13.1 Abaxis, Inc.
13.2 Abbott Laboratories
13.3 AccuBioTech Co., Ltd.
13.4 Accriva Diagnostics
13.5 ACON Laboratories, Inc.
13.8 Aerscher Diagnostics, LLC
13.9 Akers Biosciences, Inc.
13.11 Alfa Scientific Designs, Inc.
13.12 American Bio Medica Corporation
13.13 Arkray, Inc.
13.14 Atlas Genetics Ltd.
13.15 Atonomics A/S
13.16 Audit Diagnostics
13.17 Augurix Diagnostics Ltd.
13.19 Beckman Coulter (Danaher Corporation)
13.20 bioLytical Laboratories
13.21 Biomerica, Inc.
13.24 Bio-Rad Laboratories, Inc.
13.25 BioScan Screening Systems, Inc.
13.26 Calypte Biomedical Corporation
13.27 Chembio Diagnostic, Inc.
13.29 Claros Diagnostics (OPKO Healthcare)
13.30 ERBA Diagnostics, Inc.
13.31 Daktari Diagnostics
13.33 Diagnostics for All
13.34 Enigma Diagnostics Ltd.
13.35 EY Laboratoires, Inc.
13.37 Exalenz Bioscience
13.39 Guided Therapeutics, Inc.
13.40 Helena Laboratories
13.41 Hema Diagnostic Systems, LLC
13.42 Instrumentation Laboratory (IL)/Werfen Group
13.43 Jant Pharmacal Corporation
13.44 Lein Applied Diagnostics
13.45 LifeSign, LLC
13.46 Medica Corporation
13.47 Medix Biochemica
13.48 MedMira Laboratories
13.49 A. Menarini Diagnostics
13.51 New Horizons Diagnostics
13.52 Nova Biomedical
13.53 OraSure Technologies, Inc.
13.54 Orion Diagnostica
13.55 Polymedco, Inc.
13.56 Polymer Technology Systems, Inc.
13.57 Prima Biomedical Company
13.59 Quest Diagnostics, Inc.
13.60 Quidel Corporation
13.61 Radiometer Medical
13.62 Response Biomedical Corp.
13.63 Roche Diagnostics
13.64 Savyon Diagnostics
13.66 Sekisui Diagnostics, LLC
13.67 Shanghai Ruicare Medical Co., Ltd.
13.68 Shenzhen Fitconn Technology Co., Ltd.
13.69 Shionogi & Co., Ltd.
13.70 Siemens AG
13.71 Siloam Biosciences, Inc.
13.72 Spectral Diagnostics, Inc.
13.73 StatSure Diagnostic Systems, Inc.
13.74 One Step Detect Associates, LLC
13.77 Trinity Biotech Plc
13.78 Väsamed, Inc.
14. POCT Sector Trends and Forecasts
14.1 Home Care Analysis as Part of Near-Patient Testing
14.2 Non-Traditional Collection for POCT
14.3 New Systems for Critical Care and Near-Patient Testing
14.4 Utility of Near-Patient Testing in Critical-Care Settings
14.5 Physician's Office Market
14.6 Information Management Advances
14.7 Test-Ordering Patterns and Demand for POCT
14.8 Demand for Emergency Department Services
14.9 Move Away from the Central Laboratory
14.10 Healthcare Cost Controls
14.11 Mergers & Acquisitions
14.12 Competition for Services
14.13 Drivers of POCT
14.14 Confluence of New Technology
14.15 Difficulties of Design for POC Products
14.16 Point of Care Compliance
14.17 The Biggest New Opportunities in POCT
15. New Entrants to the Point of Care Market
15.1 Alliance International Co., Ltd.
15.2 Analyticon Biotechnologies AG
15.3 Ativa Medical Corporation
15.4 Aquila Diagnostic Systems, Inc.
15.5 ArcDia International Oyo Ltd.
15.6 Artron Laboratories, Inc.
15.7 Atlas Link Biotech Co., Ltd.
15.8 Audit Diagnostics
15.9 Autobio Diagnostics Co., Ltd.
15.10 Biocartis SA
15.11 BioFire Diagnostics, Inc.
15.13 Biosensia Ltd.
15.14 Curetis AG
15.15 DxNA, LLC
15.16 Echo Therapeutics, Inc.
15.17 Gentag, Inc.
15.18 Great Basin Corporation
15.19 Immunexpress Group
15.20 Integrated Diagnostics
15.21 Integrity Applications
15.22 MBio Diagnostics, Inc.
15.23 Menssana Research, Inc.
15.24 Metaara Medical Technologies, Inc.
15.25 QuantuMDx Group
15.26 Venaxis, Inc.
15.27 Philips Business Group EBA
15.28 Wave 80 Biosciences
15.29 Veredus Laboratories Pte Ltd.
For more information about this report visit
Related Topics: Point-of-Care Diagnostics
Research and Markets
Laura Wood, Senior Manager
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/global-point-of-care-diagnostic-testing-world-markets-2015-2018-featuring-100-companiesorganisations-across-25-individual-market---research-and-markets-300316270.html
SOURCE Research and Markets